Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) EBT: 2019-2024

Historic EBT for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to -$276.0 million.

  • Cellebrite DI's EBT rose 111.87% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.3 million, marking a year-over-year increase of 127.35%. This contributed to the annual value of -$276.0 million for FY2024, which is 265.24% down from last year.
  • As of FY2024, Cellebrite DI's EBT stood at -$276.0 million, which was down 265.24% from -$75.6 million recorded in FY2023.
  • Cellebrite DI's 5-year EBT high stood at $120.8 million for FY2022, and its period low was -$276.0 million during FY2024.
  • Moreover, its 3-year median value for EBT was -$75.6 million (2023), whereas its average is -$76.9 million.
  • In the last 5 years, Cellebrite DI's EBT spiked by 705.44% in 2020 and then slumped by 265.24% in 2024.
  • Cellebrite DI's EBT (Yearly) stood at $11.4 million in 2020, then spiked by 622.16% to $82.3 million in 2021, then spiked by 46.72% to $120.8 million in 2022, then crashed by 162.57% to -$75.6 million in 2023, then tumbled by 265.24% to -$276.0 million in 2024.